1. System pharmacology analysis to decipher the effect and mechanism of active ingredients combination from Duhuo Jisheng decoction on osteoarthritis in rats.
- Author
-
Zheng, Senwang, Zhou, Bo, Yang, Lin, Hou, Ajiao, Zhang, Jiaxu, Yu, Huan, Kuang, Haixue, Jiang, Hai, and Yang, Liu
- Subjects
- *
KNEE osteoarthritis , *DRUG efficacy , *INTERLEUKINS , *PROTEINS , *HERBAL medicine , *ANIMAL experimentation , *PHARMACOLOGY , *WESTERN immunoblotting , *METABOLISM , *TREATMENT effectiveness , *RATS , *QUALITATIVE research , *COMPARATIVE studies , *CELLULAR signal transduction , *ENZYME-linked immunosorbent assay , *PLANT extracts , *COMPUTER-assisted molecular modeling , *CHINESE medicine , *THERAPEUTICS , *EVALUATION - Abstract
Duhuo Jisheng decoction is a traditional Chinese formula that has been widely used in clinical practice to treat osteoarthritis, which has the effects of removing invaded cold and dampness, relieving joint pain. However, it is difficult to determine the effective substances and mechanisms due to assorted herbs and components, and further research is needed. This study was designed to explore and verify the mechanism and targets of DHJSD in the treatment of OA via network analysis and experiments. In this study, the active ingredients of DHJSD were qualitatively analyzed by UPLC-QDA. Network analysis was used to identify common targets and pathways. Next, we explored the therapeutic mechanism of DHJSD through a rat model of knee osteoarthritis. HE staining was used to judge the establishment of the animal model. ELISA and Western blotting were used to verify the expression of key pathway proteins. In this study, seventeen chemical constituents in DHJSD were identified. According to the network analysis, we obtained the potential associated pathways of action. Then, molecular docking and SPR experiments showed that the sixteen identified components had high binding energies to IL-6. HE staining showed that the high-dose group of DHJSD had an obvious therapeutic effect on model rats. Compared with the model group, the levels of IL-1β, TNF-α, IL-6, MMP3, MMP13, ADAMTS4 and ADAMTS5 in serum and the expression of STAT3 and p-STAT3 protein in administration groups were significantly decreased. This result indicated that the IL-6/STAT3 signaling pathway was one of the important pathways regulated by DHJSD to improve OA. [Display omitted] • This paper first identified 17 compounds, found that DHJSD can treat OA by regulating IL-6/STAT3 pathway in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF